Korean Biotech Roundup: GNT Set For First Direct Korean Biopharma IPO On Nasdaq

Others Sign Big Deals With Multinationals

 
• By Jung Won Shin
  
Nasdaq
ABL Bio, Other Bioventures Dominate Large Global Deals So Far (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Business